Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 01, 2018 8:23am

43 Views

Post# 28906549

RE:RE:RE:RE:RE:RE:RE:RE:135 million shares and counting

So how does Theralase go about getting the go ahead to start giving TLD 1433 I.V.??? That's where the big move will come IMO. So many other cancers could be treated (using xray rather than laser). The treatment process would be so simple unless I'm missing something? Start an I.V. Give the TLD 1433 I.V. Wait the required time and then xray the tumor area. Heck it could be done in an oncologists office where they already have the equipement......then when deemed safe it could be done anywhere?

Lives/families could be changed for the better.

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale